JSA advised TPG, in relation to the proposed merger of its investee company, Quality Care India Limited (“QCIL”), with Aster DM Healthcare Limited (“Aster”), at a combined valuation of over USD 5 billion.
The transaction also contemplates a preferential issuance by Aster, prior to the merger, for an acquisition of 5% shareholding in QCIL. The transactions are subject to applicable regulatory and corporate approvals.
The combined entity will have a network of 38 hospitals and 10,150+ beds spread across 27 cities making it one of the top 3 hospital chains in India.
Deal value: USD 5 billion (approx.)
Our transaction team comprises Lead Partners – Iqbal Khan and Ambarish, Partner – Ashid Basheer, and Senior Associate – Varun Natarajan.
Our competition team comprises Partner and Chair, Competition Law – Nisha Kaur Uberoi, Partner – Pranav Satyam, Senior Associates – Akrathi Shetty and Kamal Sharma, and Associate – Tarun Katariya.
Ambarish is an equity Partner at the Mumbai office of JSA and focuses on private and public mergers and acquisitions, and private equity investments.